These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29150054)

  • 41. Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Patwardhan M; Eckert LO; Spiegel H; Pourmalek F; Cutland C; Kochhar S; Gonik B;
    Vaccine; 2016 Dec; 34(49):6077-6083. PubMed ID: 27426627
    [No Abstract]   [Full Text] [Related]  

  • 42. Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.
    Graham PL; LaRussa PS; Kohl KS;
    Vaccine; 2007 Aug; 25(31):5763-70. PubMed ID: 17537551
    [No Abstract]   [Full Text] [Related]  

  • 43. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pellegrin S; Munoz FM; Padula M; Heath PT; Meller L; Top K; Wilmshurst J; Wiznitzer M; Das MK; Hahn CD; Kucuku M; Oleske J; Vinayan KP; Yozawitz E; Aneja S; Bhat N; Boylan G; Sesay S; Shrestha A; Soul JS; Tagbo B; Joshi J; Soe A; Maltezou HC; Gidudu J; Kochhar S; Pressler RM;
    Vaccine; 2019 Dec; 37(52):7596-7609. PubMed ID: 31783981
    [No Abstract]   [Full Text] [Related]  

  • 45. The development of standardized case definitions and guidelines for adverse events following immunization.
    Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
    Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
    [No Abstract]   [Full Text] [Related]  

  • 46. Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Kerr R; Eckert LO; Winikoff B; Durocher J; Meher S; Fawcus S; Mundle S; Mol B; Arulkumaran S; Khan K; Wandwabwa J; Kochhar S; Weeks A;
    Vaccine; 2016 Dec; 34(49):6102-6109. PubMed ID: 27431424
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Carol Liu YC; Ibekwe T; Kelso JM; Klein NP; Shehu N; Steuerwald W; Aneja S; Dudley MZ; Garry R; Munoz FM;
    Vaccine; 2020 Jun; 38(30):4717-4731. PubMed ID: 32418788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reporting of vaccine safety data in publications: systematic review.
    Bonhoeffer J; Zumbrunn B; Heininger U
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Gidudu J; Kohl KS; Halperin S; Hammer SJ; Heath PT; Hennig R; Hoet B; Rothstein E; Schuind A; Varricchio F; Walop W;
    Vaccine; 2008 Dec; 26(52):6800-13. PubMed ID: 18950670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Gravett C; Eckert LO; Gravett MG; Dudley DJ; Stringer EM; Mujobu TB; Lyabis O; Kochhar S; Swamy GK;
    Vaccine; 2016 Dec; 34(49):6084-6092. PubMed ID: 27461459
    [No Abstract]   [Full Text] [Related]  

  • 51. Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Rouse CE; Eckert LO; Muñoz FM; Stringer JSA; Kochhar S; Bartlett L; Sanicas M; Dudley DJ; Harper DM; Bittaye M; Meller L; Jehan F; Maltezou HC; Šubelj M; Bardaji A; Kachikis A; Beigi R; Gravett MG;
    Vaccine; 2019 Dec; 37(52):7585-7595. PubMed ID: 31783980
    [No Abstract]   [Full Text] [Related]  

  • 52. Reporting side-effects.
    Lindquist M; Edwards IR
    Lancet; 1992 Oct; 340(8826):1043. PubMed ID: 1357436
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data.
    Rouse CE; Eckert LO; Wylie BJ; Lyell DJ; Jeyabalan A; Kochhar S; McElrath TF;
    Vaccine; 2016 Dec; 34(49):6069-6076. PubMed ID: 27426628
    [No Abstract]   [Full Text] [Related]  

  • 54. Surveillance of adverse effects following vaccination and safety of immunization programs.
    Waldman EA; Luhm KR; Monteiro SA; Freitas FR
    Rev Saude Publica; 2011 Feb; 45(1):173-84. PubMed ID: 21181055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Kachikis A; Eckert LO; Walker C; Bardají A; Varricchio F; Lipkind HS; Diouf K; Huang WT; Mataya R; Bittaye M; Cutland C; Boghossian NS; Mallett Moore T; McCall R; King J; Mundle S; Munoz FM; Rouse C; Gravett M; Katikaneni L; Ault K; Klein NP; Roberts DJ; Kochhar S; Chescheir N;
    Vaccine; 2019 Dec; 37(52):7610-7622. PubMed ID: 31783982
    [No Abstract]   [Full Text] [Related]  

  • 56. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.
    Poli F; Overeem S; Lammers GJ; Plazzi G; Lecendreux M; Bassetti CL; Dauvilliers Y; Keene D; Khatami R; Li Y; Mayer G; Nohynek H; Pahud B; Paiva T; Partinen M; Scammell TE; Shimabukuro T; Sturkenboom M; van Dinther K; Wiznitzer M; Bonhoeffer J
    Vaccine; 2013 Jan; 31(6):994-1007. PubMed ID: 23246545
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaccination in preterm and low birth weight infants in India.
    Soans S; Mihalyi A; Berlaimont V; Kolhapure S; Dash R; Agrawal A
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-12. PubMed ID: 33599562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detecting adverse drug reactions.
    Rosenbloom D; Wynne C
    CMAJ; 1999 Aug; 161(3):247-8. PubMed ID: 10463044
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa, Democratic Republic of the Congo.
    Gadoth A; Mukadi Nkamba D; Arena PJ; Hoff NA; Dzogang C; Kampilu D; Beya M; Wong HL; Anderson SA; Kaba D; Rimoin AW
    Vaccine; 2022 Jun; 40(26):3605-3613. PubMed ID: 35570074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pathirana J; Muñoz FM; Abbing-Karahagopian V; Bhat N; Harris T; Kapoor A; Keene DL; Mangili A; Padula MA; Pande SL; Pool V; Pourmalek F; Varricchio F; Kochhar S; Cutland CL;
    Vaccine; 2016 Dec; 34(49):6027-6037. PubMed ID: 27449077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.